Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-01-03 Sale | 2024-01-05 7:58 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 33,190 | $34.36 | $1,140,362 | 464,385 (Direct) | View |
| 2023-01-05 Sale | 2023-01-06 7:30 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 15,000 | $37.39 | $560,850 | 413,375 (Direct) | View |
| 2023-01-03 Sale | 2023-01-05 7:10 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 17,500 | $38.33 | $670,802 | 428,375 (Direct) | View |
| 2022-01-05 Sale | 2022-01-07 8:16 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 32,500 | $61.72 | $2,005,875 | 348,075 (Direct) | View |
| 2021-02-08 Sale | 2021-02-10 5:56 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 90,000 | $88.46 | $7,961,240 | 353,375 (Direct) | View |
| 2021-01-06 Sale | 2021-01-07 6:11 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 25,000 | $72.41 | $1,810,346 | 293,375 (Direct) | View |
| 2020-01-06 Sale | 2020-01-08 6:33 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 14,625 | $60.12 | $879,261 | 258,375 (Direct) | View |
| 2019-05-28 Sale | 2019-05-29 7:01 pm | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 30,000 | $24.88 | $746,400 | 203,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-04 Option Award | 2024-01-05 7:58 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 85,000 | $0 | 464,385 (Direct) | View |
| 2023-01-04 Option Award | 2023-01-05 7:10 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick COO and General Counsel | 65,000 | $0 | 428,375 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-22 8:01 pm | 2016-02-01 2026-01-01 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 32,000 | $0 | 380,875 (Direct) | View |
| 2022-12-21 Exercise | 2022-12-22 8:01 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 32,000 | $6.15 | 380,875 (Direct) | View |
| 2020-12-04 Gift | 2022-01-07 8:16 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 800 | $0 | 348,075 (Direct) | View |
| 2021-12-31 Exercise | 2022-01-04 9:26 pm | 2016-02-01 2026-01-01 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 28,000 | $0 | 413,375 (Direct) | View |
| 2021-12-31 Exercise | 2022-01-04 9:26 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 28,000 | $6.15 | 413,375 (Direct) | View |
| 2022-01-01 Option Award | 2022-01-04 9:26 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 60,000 | $0 | 413,375 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 5:56 pm | 2015-06-02 2024-12-02 | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 90,000 | $0 | 353,375 (Direct) | View |
| 2021-02-08 Exercise | 2021-02-10 5:56 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 90,000 | $5.22 | 353,375 (Direct) | View |
| 2021-01-01 Option Award | 2021-01-05 6:27 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 60,000 | $0 | 318,375 (Direct) | View |
| 2020-01-01 Option Award | 2020-01-03 6:02 pm | N/A N/A | ARROWHEAD PHARMACEUTICALS INC. | ARWR | O'Brien Patrick General Counsel | 70,000 | $0 | 273,000 (Direct) | View |